Cement currently ranks as the third largest source of human-generated CO2 – after power and transport. It accounts for roughly 7% of all anthropogenic emissions . Globally, we produce over 4bn t of cement per year, which equates to around 560kg for every person on earth – with demand for concrete rising faster than demand for steel or timber.
Helium is a finite resource that plays a critical role across several industries including medical imaging, thermal management systems for batteries, aerospace engineering, chemicals and pharmaceuticals, semiconductor manufacturing and fibre optics. Helium’s high thermal conductivity, chemical inertness and cryogenic properties uniquely lend themselves to applications with limited or no available alternatives in some cases.
Diversity and inclusion are important for any business. Increasingly, employers are recognising that recruiting a workforce from different cultures and backgrounds is not only progressive, but also makes good business sense.
Every time it rains, a toxic cocktail of pollutants runs off the UK’s road network and into our rivers and water sources. The pollution comes from tyre particles, fuel spills and other vehicle fluids, road surface fragments, sediment and herbicides. These contain heavy metals and toxic chemicals such as polyaromatic hydrocarbons (PAHs), known to be carcinogenic and hormone disrupting to aquatic life.
Plastic packaging waste is a problem that isn’t getting smaller. Despite the many initiatives, targets and corporate ESG commitments, plastic packaging on the market in the UK totals 2.3m t, according to charity WRAP, with plastic packaging now accounting for nearly 70% of the UK’s plastic waste. This figure is unsustainable and doing untold damage to the environment.
Technology should be a means of easing frustration and confusion, but in today’s digital world consumers increasingly report feeling overwhelmed and exhausted by their digital lives and turned off by all but the most seamless digital interactions.
If you discovered your country was losing up to £78bn a year, you would want to do something about it, right? Well, that is how much the UK loses to workplace sickness and ill-health each year.
If you discovered your country was losing up to £78bn a year, you would want to do something about it, right? Well, that is how much the UK loses to workplace sickness and ill-health each year.
Getting the right medicine, to the right patient, at the right time, has long been the central mantra of those involved in the generic and biosimilar industries. The UK has been regarded with envy by other countries due to the success of its competitive off-patent medicines market, which has consistently delivered huge savings to the NHS while also guaranteeing security of supply. Four out of every five prescription medicines are met by generics or biosimilars and they are fundamental to the safe running of the NHS as well as the health and well-being of its patients.
Developing a comprehensive strategy for protecting your innovation is essential to protecting your company’s assets. Many innovations protected by applying for a patent could also be protected as trade secrets. A granted patent provides rights to exclude others from using the patented invention for a period of up to 20 years from filing. By contrast, there is no fixed term of protection for trade secrets. A trade secret may retain the exclusive innovation of a company for as long as it remains secret.